Baby swabs and nasal swabs recalled for possible fungus in swab parts
That's what manufacturer Church & Dwight said in its notice announcing the recall of Orajel Baby Teething Swabs, Zicam Cold Remedy Nasal Swabs and Zicam Nasal AllClear Swabs from stores across the United States, including Puerto Rico.
The lots and expiration dates involved? All.
READ MORE: Recalled UTI drug could have deadly microbial contamination
Swabs with a microbial contamination can cause 'serious and life-threatening blood infections in users whose nasal mucosa may be compromised due to inflammation and mechanical injurie,' the recall notice states. 'The risk is highest (potentially severe or life-threatening) among children and individuals with compromised immune systems or other underlying medical conditions.'
▪ Zicam Cold Remedy Nasal Swabs carry UPC No. 732216301205.
▪ Zicam Nasal AllClear Swabs, which were discontinued in December, carry UPC No. 732216301656.
▪ Orajel baby swabs carry UPC No. 310310400002.
If you have the swabs, throw them in the trash or, for a refund, reach out go Church & Dwight either online or by calling 800-981-4710. Questions can be directed to that phone number, 9 a.m. to 5 p.m., Monday through Friday.
If you think you or your baby is having a medical issue caused by these swabs, go see a medical professional. Then, notify the FDA's MedWatch Adverse Event Program, either by filling out a form online or by requesting a reporting form at 800-332-1088.
Then, third, call Church & Dwight.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
41 minutes ago
- Business Upturn
Respiree Secures Second FDA 510(k) Clearance, Expands Cardio-Respiratory Wearable to Home Use via 1Bio™ Connected Care Platform
By GlobeNewswire Published on August 6, 2025, 03:25 IST HOUSTON and SINGAPORE, Aug. 05, 2025 (GLOBE NEWSWIRE) — Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, today announced it has received its second U.S. Food and Drug Administration (FDA) 510(k) clearance. The clearance expands the use of its RS001 cardio-respiratory wearable to home environments and includes approval for its connected care platform marketed as 1Bio™. Illustrative Image of Respiree's RS001 Wearable With its Connected Care 1Bio™ Platform The RS001 is a chest-worn device that directly measures respiration and offers passive cardio-respiratory monitoring. Originally cleared for in-patient clinical use, the RS001's use in home settings marks a significant step toward more accessible and preventive healthcare. The device connects to a cellular hub, which enables data to be visualized in real time via the connected care 1Bio™ dashboard. 'Respiration is the most predictive vital sign for clinical deterioration, yet it remains underutilized – particularly outside hospital settings,' said Dr. Gurpreet Singh, CEO and Founder of Respiree. 'This FDA 510(k) extension allows healthcare systems to passively and accurately monitor leading indicators in the home, enabling earlier interventions and reducing the overall burden on healthcare infrastructure.' The announcement follows Respiree's recent US$11.6 million Series A financing round, led by We Venture Capital and ClavystBio, which will accelerate development toward potential regulatory approvals and global market expansion. Respiree also announced plans to pursue additional FDA clearances for its proprietary AI software, aiming to integrate artificial intelligence models into the 1Bio™ platform for both inpatient and home-based care. 'These are exciting times for us,' added Dr. Singh. 'Our first 510(k) was for the wearable; this second one is for the platform. We are now focused on bringing our flagship AI models into the fold as a Software as a Medical Device (SaMD).' About Respiree Respiree™ is an AI/ML health tech company building state-of-the-art clinically-validated artificial intelligence (AI) for managing disease progression across healthcare's care continuum. The 1Bio™ platform by Respiree™ uses data from the EHR and its proprietary US-patented and FDA-cleared sensors to longitudinal measure and track disease progression. Respiree™ is now available in U.S., Australia and Asia-Pacific (APAC). Respiree™ is CE marked, has received regulatory clearances in Australia from the Therapeutics Goods Administration and has received the 510k clearance from the United States Food and Drug Administration (FDA). ( Media Enquiries Evangeline Fu Administrative Manager Respiree Pte Ltd Email: [email protected] A photo accompanying this announcement is available at Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
USA Today
an hour ago
- USA Today
NFL reveals reasons why smelling salts are banned in 2025
The 2025 season will introduce some new rules and technology to the NFL, but one change in particular has upset one of the league's best tight ends. The San Francisco 49ers' George Kittle interrupted an interview on NFL Network to voice his displeasure over a new rule banning smelling salts. "I honestly just came up here to air a grievance," Kittle said during an episode of "Inside Training Camp Live" featuring teammate Fred Warner. "Our team got a memo today that smelling salts and ammonia packets were made illegal in the NFL. And I've been distraught all day." Kittle was especially upset because he uses smelling salts often during NFL games. "I'm an every drive guy," Kittle said. "I considered retirement. We got to figure out a middle ground here guys. Somebody help me out, somebody come up with a good idea... I miss those already." Jordan Addison suspension: Vikings WR gets three game ban, NFL announces Training camp scuffle: Baltimore Ravens and Indianapolis Colts get into joint practice brawl That's an under-the-radar change that will impact players across the league. USA TODAY Sports obtained the league memo and here's what the NFL told teams. NFL statement on smelling salts A league official confirmed to USA TODAY Sports that the teams are now prohibited from providing players smelling salts during games. The official declined to be identified because of the sensitivity of the matter. The memo that the NFL sent to teams today read: "In 2024, the FDA issued a warning to companies that produce commercially available ammonia inhalants (AIs), as well as to consumers about the purchase and use of AIs, regarding the lack of evidence supporting the safety or efficacy of AIs marketed for improving mental alertness or boosting energy. The FDA noted potential negative effects from AI use. AIs also have the potential to mask certain neurologic signs and symptoms, including some potential signs of concussion. As a result, the NFL Head, Neck, and Spine Committee recommended prohibiting the use of AIs for any purpose during play in the NFL. In light of this information, effective for the 2025 NFL season, clubs are prohibited from providing or supplying ammonia in any form at NFL games. For clarity, 'ammonia' refers to ammonia capsules, inhalers, ammonia in a cup, and any form of 'smelling salts.' This prohibition applies to all club personnel (including but not limited to team physicians, athletic trainers, strength and conditioning coaches and coaches or other personnel). The prohibition applies through the entirety of all NFL games, including during all pregame activities, and halftime, and applies on the sideline and in stadium locker rooms." NFL players have used smelling salts for years, and it isn't the first sport to ban them. Many boxing organizations banned them years ago because they can mask a severe injury.
Washington Post
an hour ago
- Washington Post
How much sugar is in orange juice? Here's what to know.
The Food and Drug Administration on Tuesday proposed a tweak to reduce the amount of sugar required in pasteurized orange juice. But the news from the Trump administration isn't a proposal to lower the amount of sugar in the American diet; it's intended to help Florida's citrus industry because the sugar content of Florida oranges has been steadily dropping due to a bacterial disease afflicting the crop.
